Neogen Chemicals Ltd. (IN:NEOGEN)
:NEOGEN
Want to see IN:NEOGEN full AI Analyst Report?
NEOGEN Stock Chart & Stats
₹1156.90
₹9.65(0.45%)
At close: 4:00 PM EST
₹1156.90
₹9.65(0.45%)
Day’s Range― - ―
52-Week Range₹978.00 - ₹1,958.55
Previous CloseN/A
Volume22.32K
Average Volume (3M)9.36K
Market Cap
₹49.49B
Enterprise Value₹62.92B
Total Cash (Recent Filing)₹5.00B
Total Debt (Recent Filing)₹11.32B
Price to Earnings (P/E)174.6
Beta1.44
Next Earnings
Aug 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.09%
Share Statistics
EPS (TTM)9.88
Shares Outstanding26,381,674
10 Day Avg. Volume1,157
30 Day Avg. Volume9,357
Financial Highlights & Ratios
PEG Ratio-5.85
Price to Book (P/B)3.59
Price to Sales (P/S)3.40
P/FCF Ratio-3.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.97
Revenue Forecast (FY)₹12.52B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained multi-year top-line growth signals durable end-market demand and successful customer qualification across pharma, agro and industrial segments. A larger revenue base supports scale economies, product development and negotiating leverage with suppliers, helping stabilize margins over time if execution improves.
Specialty Chemistry FocusConcentrated expertise in bromine- and lithium-based intermediates creates differentiated, hard-to-replicate capabilities. Specialized chemistries and quality requirements raise technical barriers, enabling stickier customer relationships, higher switching costs and potential pricing power in regulated end markets like pharma.
Custom Manufacturing & ContractsContract manufacturing and long-term supply agreements provide structural revenue visibility and customer lock-in once products are qualified. These relationships reduce sales volatility, support repeatable volumes, and can underpin predictable capacity utilization and margin recovery if working-capital and cost issues are managed.
Bears Say
Margin CompressionSharp gross- and net-margin deterioration erodes return on invested capital and limits internal funding for R&D, capex and debt reduction. If driven by structural pricing pressure or adverse mix, reduced profitability weakens the firm's ability to absorb input-cost shocks and sustain long-term competitiveness.
Rising LeverageA rapid increase in debt materially raises refinancing and interest-rate risk, constraining strategic flexibility. With profitability down, higher leverage increases covenant and liquidity vulnerability, making funding for growth or unexpected setbacks more costly and prolonging recovery if cash flow remains weak.
Weak Cash GenerationPersistent negative operating and free cash flow create structural dependence on external financing and reduce the firm's ability to deleverage or invest. Large cash burn suggests working-capital strain or heavy capex that, absent margin recovery, heightens execution and funding risk over the medium term.
Neogen Chemicals Ltd. News
NEOGEN FAQ
What was Neogen Chemicals Ltd.’s price range in the past 12 months?
Neogen Chemicals Ltd. lowest stock price was ₹978.00 and its highest was ₹1958.55 in the past 12 months.
What is Neogen Chemicals Ltd.’s market cap?
Neogen Chemicals Ltd.’s market cap is ₹49.49B.
When is Neogen Chemicals Ltd.’s upcoming earnings report date?
Neogen Chemicals Ltd.’s upcoming earnings report date is Aug 03, 2026 which is in 59 days.
How were Neogen Chemicals Ltd.’s earnings last quarter?
Neogen Chemicals Ltd. released its earnings results on May 16, 2026. The company reported ₹4.32 earnings per share for the quarter, beating the consensus estimate of ₹2 by ₹2.32.
Is Neogen Chemicals Ltd. overvalued?
According to Wall Street analysts Neogen Chemicals Ltd.’s price is currently Overvalued.
Does Neogen Chemicals Ltd. pay dividends?
Neogen Chemicals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.09%. See more information on Neogen Chemicals Ltd. dividends here
What is Neogen Chemicals Ltd.’s EPS estimate?
Neogen Chemicals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neogen Chemicals Ltd. have?
Neogen Chemicals Ltd. has 26,381,674 shares outstanding.
What happened to Neogen Chemicals Ltd.’s price movement after its last earnings report?
Neogen Chemicals Ltd. reported an EPS of ₹4.32 in its last earnings report, beating expectations of ₹2. Following the earnings report the stock price went down -0.898%.
Which hedge fund is a major shareholder of Neogen Chemicals Ltd.?
Currently, no hedge funds are holding shares in IN:NEOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neogen Chemicals Ltd.
Neogen Chemicals Limited manufactures and sells specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; inorganic bromine compounds and lithium salts; grignard reagents; and advance intermediates. The company also provides custom synthesis and manufacturing services. It serves pharmaceutical, agrochemical, engineering, flavour and fragrance, electronic-chemical, refrigeration, construction chemicals, pharmaceutical, and specialty polymer industries, as well as heating, ventilation, and air-conditioning industries. The company also exports its products to 28 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Balaji Amines Limited
―
Laxmi Organic Industries Ltd.
―
Tatva Chintan Pharma Chem Limited
―
Vishnu Chemicals Limited
―